Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain

Trescot AM, Datta S, Lee M, Hanssen H: Opioid pharmacology. Pain Pysician. 2008, 11: S133-S153.

Waldhoer M, Barlett SE, Whistler JL: Opioid receptors. Ann Rev Biochem. 2004, 73: 753-990. 10.1146/annurev.biochem.73.011303.073940.

Mao J, Gols MS, Backonja MM: Combination drug therapy for chronic pain: a call for more clinical studies. J Pain. 2011, 12: 157-166. 10.1016/j.jpain.2010.07.006.

Lashbrook JM, Ossipov MH, Hunter JC, Raffa RB, Tallarida RJ, Porreca F: Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats. Pain. 1999, 82: 65-72. 10.1016/S0304-3959(99)00031-7.

Miranda HF, Puig MM, Prieto JC, Pinardi G: Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain. 2006, 121: 22-28. 10.1016/j.pain.2005.11.012.

Miranda HF, Puig MM, Romero MA, Prieto JC: Effect of tramadol and dexketoprofen on analgesia and gastrointestinal transit in mice. Fund Clin Pharmacol. 2009, 23: 81-88. 10.1111/j.1472-8206.2008.00636.x.

Silva-Moreno A, Gonzalez-Espinosa CM, Cruz SL: Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization. Eur J Pharmacol. 2012, 674: 239-247. 10.1016/j.ejphar.2011.10.034.

Ramiro S, Radner H, Van der Heijde DM, Buchbinder R, Aletaha D, Landewé RB: Combination therapy for pain management in inflammatory arthritis: a Cochrane systematic review. J Rheumatol. 2012, 90: 47-55.

Kolesnikov YA, Oksman G, Pasternak GW: Topical methadone and meperidine analgesic synergy in the mouse. Eur J Pharmacol. 2010, 38: 61-64. 10.1016/j.ejphar.2010.04.020.

Miranda HF, Noriega V, Zepeda RJ, Sierralta F, Prieto JC: Synergism between fentanyl and tramadol in tonic inflammatory pain: the orofacial formalin test. Inflammation. 2012, 35: 1132-1137. 10.1007/s10753-011-9420-7.

Whittle SL, Richards BL, Husni E, Buchbinder R: Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev. 2011, ᅟ (11): CD003113-doi:10.1002/14651858.CD003113.pub3

Kurihara T, Nonaka T, Tanabe T: Acetic acid conditioning stimulus induced long-lasting antinociception of somatic inflammatory pain. Pharmacol Biochem Behav. 2003, 74: 841-849. 10.1016/S0091-3057(03)00014-5.

Pavao-de-Souza G, Zarpelon F, Tedeschi AC, Mizokami GC, Sanson SS, Cunha TM, Ferreira SH, Cunha FQ, Casagrande R, Verri WA: Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI (3)K and microglia in mice. Pharmacol Biochem Behav. 2012, 101: 320-328. 10.1016/j.pbb.2012.01.018.

Le Bars D, Gozariu M, Cadden SW: Animal models of nociception. Pharmacol Rev. 2001, 53: 597-652.

Koster R, Anderson M, de Beer EJ: Acetic acid for analgesic screening. Fed Proc. 1959, 18: 412-414.

Eddy NB, Leimbach D: Synthetic analgesics: II dithienylbutenyl- and dithienylbutenylamines. J Pharmacol Exp Ther. 1953, 107: 385-393.

Tallarida RJ: Drug synergism and dose-effect data analysis. 2000, Chapman & Hall/CRC Press. USA, Boca Ratón

Takemori AE, Ho BY, Naeseth JS, Portoghese PS: Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther. 1988, 246: 255-258.

Suzuki T, Narita M, Takahashi Y, Misawa M, Nagase H: Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur J Pharmacol. 1992, 213: 91-97. 10.1016/0014-2999(92)90237-X.

Satyanarayana PSV, Jain NK, Singh A, Kulkarni SK: Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice. Prog Neuropsychopharmacol Biol Psychiatr. 2004, 28: 641-649. 10.1016/j.pnpbp.2004.01.015.

Naidu PS, Lichtman AH, Archer CC, May EL, Harris LS, Aceto MD: NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action. Eur J Pharmacol. 2007, 566: 132-136. 10.1016/j.ejphar.2007.03.031.

Mary F, Divin MF, Holden Ko MC, Traynor JR: Comparison of the opioid receptor antagonist properties of naltrexone and 6β-naltrexol in morphine-naïve and morphine-dependent mice. Eur J Pharmacol. 2008, 583: 48-55. 10.1016/j.ejphar.2008.01.004.

Loscalzo LM, Wasowski C, Paladini AC, Marder M: Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur J Pharmacol. 2008, 580: 306-313. 10.1016/j.ejphar.2007.11.011.

Reichter A, Daughters RS, Rivard R, Simone DA: Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain. 2001, 89: 221-227. 10.1016/S0304-3959(00)00365-1.

Raynor K, Kong H, Chen Y, Yasuda Y, Bell GI, Reisine T: Pharmacological characterization of cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol. 1994, 45: 330-334.

Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, Selve N: Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exper Ther. 1993, 267: 331-340.

McQuay HJ, Sullivan AF, Smallman K, Dickenson H: Intrathecal opioids, potency and lipophilicity. Pain. 1989, 36: 111-115. 10.1016/0304-3959(89)90118-8.

Miranda HF, Silva E, Pinardi G: Synergy between the antinociceptive effects of morphine and NSAIDs. Can J Physiol Pharmacol. 2004, 82: 331-338.

Romero A, Miranda HF, Puig MM: Antinociceptive effects of morphine, fentanyl, tramadol and their combination, in morphine-tolerant mice. Pharmacol Biochem Behav. 2010, 97: 363-369. 10.1016/j.pbb.2010.09.005.

Sirohi S, Dighe SV, Walker EA, Yoburn CB: The analgesic efficacy of fentanyl: relation to tolerance and μ-opioid receptor regulation. Pharmacol Biochem Behav. 2008, 91: 115-120. 10.1016/j.pbb.2008.06.019.

Collier HOJ, Dinneen LC, Johnson CA, Schneider C: The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother. 1968, 32: 295-310. 10.1111/j.1476-5381.1968.tb00973.x.

Neelakantan H, Walker EA: Temperature-dependent enhancement of the antinociceptive effects of opioids in combination with gabapentin in mice. Eur J Pharmacol. 2012, 686: 55-59. 10.1016/j.ejphar.2012.04.042.

Lemberg K, Kontinen VS, Viljakka K, Kylânlathi I, Yli-Kauhaluoma J, Kalso E: Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat. Anesth Anal. 2006, 102: 1768-1774. 10.1213/01.ane.0000205751.88422.41.

Pan YX, Xu J, Bolan E, Moskowitz HS, Xu M, Pasternak GW: Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol Pharmacol. 2005, 68: 866-875.

Hojo M, Sudo Y, Ando Y, Minami K, Takada M, Matsubara T, Kanaide M, Taniyama K, Sumikawa K, Uezono Y: Mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. J Pharmacol Sci. 2008, 108: 308-319.

Barrera NP, Morales B, Torres S, Villalón M: Principles: mechanisms and modeling of synergism in cellular responses. Trends Pharmacol Sci. 2005, 26: 526-532. 10.1016/j.tips.2005.08.003.

Simmons DL, Botting RM, Timothy HLA: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004, 56: 387-437. 10.1124/pr.56.3.3.

Zhang Z, Pan ZZ: Synaptic mechanism for functional synergism between δ- and μ- opioid receptors. J Neurosci. 2010, 30: 4735-4745. 10.1523/JNEUROSCI.5968-09.2010.